Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1248-1257

  Hopkins, Robert B ^a,b   Garg, Amit X ^c   Levin, Adeera ^d   Molzah, Anita ^e   Rigatto, Claudio ^f   Singer, Joel ^d   Soltys, George ^g   Soroka, Steven ^h   Parfrey, Patrick S ⁱ   Barrett, Brendan J ⁱ   Goeree, Ron ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g HÔPITAL CHARLES LEMOYNE   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANEMIA; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETERIZATION; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSLIPIDEMIA; ECHOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING CARE; OCCUPATIONAL THERAPIST; PHYSIOTHERAPIST; PROSPECTIVE STUDY; PROTEINURIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION;

AGED; BIOLOGICAL MARKERS; CANADA; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COST SAVINGS; COST-BENEFIT ANALYSIS; CREATININE; DISEASE PROGRESSION; DRUG COSTS; FEMALE; GENERAL PRACTICE; GLOMERULAR FILTRATION RATE; HEALTH CARE COSTS; HEMATINICS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; KIDNEY; KIDNEY DISEASES; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, ECONOMIC; NURSE CLINICIANS; PATIENT CARE TEAM; PLATELET AGGREGATION INHIBITORS; PREVENTIVE HEALTH SERVICES; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 79958203072     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07180810     Document Type: Article

References (30)

1. Song G, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW: Hemmelgarn BR: Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 18: 2953-2959, 2007
2. Garg AX, Mamdani M, Juurlink DN, van Walraven C: Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance. J Am Soc Nephrol 16: 1433-1439, 2005
3. Canada Health Infoway. Available at http://www.infowayinforoute. ca/lang-en/about-infoway/news/news-releases/149- online-tool-will-support-ontarians-with-chronic-kidney-disease- in-management-of-their-own-care. Accessed January 8, 2010
4. Smith D, Gullion C, Nichols G, Keith D, Brown J: Cost of Medical Care for Chronic Kidney Disease and Comorbidity among Enrollees in a Large HMO Population. J Am Soc Nephrol 5: 1300-1306, 2004
5. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE Randomized Trial. Ann Intern Med 134: 707-709, 2001
6. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001
7. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: Meta-analysis andmeta-regression of randomised controlled trials. BMJ 336: 645-651, 2008
8. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 12: 1713-1720, 2001
9. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with renal insufficiency. Am J Kidney Dis 37: 484-489, 2001
10. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS: Cardiovascular disease risk factors in chronic kidney disease: Overall burden andrates of treatment and control. Arch Intern Med 166: 1884-1891, 2006
11. Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C. Early referral strategies for management of people with markers of renal disease: A systematic review of the evidence of clinical effectiveness, cost effectiveness and economic analysis. Health Technol Assess 14: 1-184, 2010
12. McLaughlin K, Manns B, Culleton B, Donaldson C, Taub K: An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 38: 1122-1128, 2001
13. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults. A cost-effective analysis. JAMA 290: 3101-3114, 2003
14. Atthobari J, Asselbergs FW, Boersma C, de VR, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ: Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the Prevention of Renal and Vascular Endstage Disease (PREVEND) study and the Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT). Clin Ther 28: 432-444, 2006
15. Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL: Delivery patterns of recommended chronic kidney disease care in clinical practice: Administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 12: 41-52, 2008
16. Patwardhan MB, Matchar DB, Samsa GP, Haley WE: Opportunities for improving management of advanced chronic kidney disease[b]. Am J Med Qual 23: 184-192, 2008
17. Jones C, Roderick P, Harris S, Rogerson M: Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 21: 2133-2143, 2006
18. Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, Singer J, Soltys G, Soroka S, Ayers D, Parfrey PS: A nursecoordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: A randomized controlled trial. Clin J Am Soc Nephrol 2011, in press
19. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300, 1995
20. Ontario Ministry of Health and Long term Care; Ontario Case Costing Initiative. http://www.occp.com. Accessed June 3, 2009
21. Ontario Ministry of Health and Long Term Care: Ontario Health Insurance (OHIP)Schedule of Benefits and Fees. Available at http://www.health.gov.on.ca/english/providers/program/ ohip/sob/sob_mn.html. Accessed June 3, 2009
22. Jeff Packer MSW and Associates. Available at http://www. jeffpacker.com/policies.html. Accessed June 2009
23. Ontario Ministry of Health and Long Term care. Medscheck Consult. Available at http://www.health.gov.on.ca/cs/medscheck/ pub_new.html. Accessed June 3, 2009
24. Ontario Physiotherapists Association. Available at http://www. opa.on.ca/IN_THE_NEWS_FSCO_060608.SHTML. Accessed June 3, 2009
25. Health Canada: Provincial submission to the Canada Health Act Annual Report 2005-2006. Available at http://www.hc-sc. gc.ca/hcs-sss/medi-assur/cha-lcs/pt-plans-on-eng.php. Accessed June 3, 2009
26. Statistics Canada. Latest statistics (monthly). Available at http://www40.statcan.gc.ca/l01/cst01/media01-eng.htm? sdi_average%20weekly%20earnings. Last accessed June 2009
27. Ontario Nursing Association. Salary facts. Available at http:// www.ona.org/node/68. Accessed June 3, 2009
28. Health Utilities Inc. Available at http://www.healthutilities. com/hui3.htm. Accessed July 16, 2009
29. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): Concepts, measurement properties and applications. Health Qual Life Outcomes 1: 54, 2003
30. Guidelines for the economic evaluation of health technologies: Canada [3rd Edition], Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health, 2006